Chemotherapy is the process of introducing cancer retarding drugs into a patient’s body to slow the rapid division of cancer cells. While it’s rarely used on its own, it has often proved useful to control mesothelioma tumors prior to surgery, and to help eradicate cancerous residues directly after a surgical procedure.
Chemotherapy can be administered orally, intravenously, or via isolated perfusion or infusion where the drugs are applied directly to the tumor or tumor site during an operation. Intravenous administration is the most common method of introducing the drugs to the body.
While a chemotherapy regimen can be used as ambient control of cancerous growths, in regards to malignant mesothelioma it’s normally prescribed as one of the following:
Neoadjavant chemotherapy describes a chemical treatment used to attack and shrink tumors or other malignant mesothelioma growths prior to a surgical procedure.
Adjuvant chemotherapy refers to the direct application of chemotherapy drugs to the tumor site after an operation to destroy cancerous residues a surgeon is unable to remove from the body.
Palliative chemotherapy refers to a wide range of different chemotherapy regimens used to control the symptoms of mesothelioma and improve a patient’s comfort and quality of life.
Various chemotherapy drugs are often used in combination according to a medical professional’s recommendations to better suit the unique needs of each patient.